Literature DB >> 2014639

Leaky transcription termination produces larger and smaller than genome size hepatitis B virus X gene transcripts.

W T Guo1, J Wang, G Tam, T S Yen, J S Ou.   

Abstract

The genomic DNA of hepatitis B virus (HBV) is circular and has only one known transcription termination site. The HBV X protein coding sequence is flanked by this transcription termination site at the 3' end and a promoter element at the 5' end. Transcription initiating from the X promoter and terminating at the termination site would produce a transcript 0.7 kb in length, which we have detected in cell lines that produce HBV particles. Unexpectedly, a 3.9-kb transcript containing two copies of the X gene sequence was also detected in these cell lines. Polymerase chain reaction analysis indicates that this 3.9-kb transcript contains sequences from both upstream and downstream of the termination site. Thus, transcription of this 3.9-kb transcript initiates from the X promoter, reads through the termination site, and terminates the second time it encounters the site. Analysis using an SV40-derived vector indicates that the transcription termination site in the HBV genome is also leaky for X gene transcription when a heterologous promoter initiates the transcription. Based on these results, the mechanism of how the transcription termination of HBV mRNA is regulated is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014639     DOI: 10.1016/0042-6822(91)90896-j

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice.

Authors:  S Perfumo; L Amicone; S Colloca; M Giorgio; L Pozzi; M Tripodi
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 2.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Detection of a hepatitis B virus variant with a truncated X gene and enhancer II.

Authors:  R Repp; C Keller; A Borkhardt; A Csecke; S Schaefer; W H Gerlich; F Lampert
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Characterization of the hepatitis B virus EnhI enhancer and X promoter complex.

Authors:  W T Guo; K D Bell; J H Ou
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation.

Authors:  N Kuzhandaivelu; Y S Cong; C Inouye; W M Yang; E Seto
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

6.  The new core promoter element XCPE1 (X Core Promoter Element 1) directs activator-, mediator-, and TATA-binding protein-dependent but TFIID-independent RNA polymerase II transcription from TATA-less promoters.

Authors:  Yumiko Tokusumi; Ying Ma; Xianzhou Song; Raymond H Jacobson; Shinako Takada
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

7.  The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication.

Authors:  Donna Sir; Yongjun Tian; Wen-ling Chen; David K Ann; Tien-Sze Benedict Yen; Jing-Hsiung James Ou
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

8.  Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor.

Authors:  J Li; J H Ou
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Duck hepatitis B virus expresses a regulatory HBx-like protein from a hidden open reading frame.

Authors:  S F Chang; H J Netter; E Hildt; R Schuster; S Schaefer; Y C Hsu; A Rang; H Will
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

10.  Aberrant tissue specific expression of the transgene in transgenic mice that carry the hepatitis B virus genome defective in the X gene.

Authors:  H Nagashima; M Imai; Y Iwakura
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.